Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer-Reference-Cited by-同舟云学术

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer

Published:2014-04-04 Issue:5 Volume:31 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Koie Takuya,Ohyama Chikara,Yamamoto Hayato,Imai Atsushi,Hatakeyama Shingo,Yoneyama Takahiro,Hashimoto Yasuhiro,Yoneyama Tohru,Tobisawa Yuki

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-014-0949-9.pdf

Reference24 articles.

1. Manoharan M, Katkoori D, Kishore TA, Kava B, Singal R, Soloway MS. Outcome after radical cystectomy in patients with clinical T2 bladder cancer in whom neoadjuvant chemotherapy has failed. BJU Int. 2009;104:1646–9.

2. Hautman RE, de Petriconi RC, Pfeiffer C, Volkmer BG. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol. 2012;61:1039–47.

3. Gore JL, Litwin MS, Lai J, Yano EM, Madison R, Setodji C, et al. Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst. 2010;102:802–11.

4. de Vries RR, Nieuwenhuijzen JA, Vincent A, van Tinteren H, Horenblas S. Survival after cystectomy for invasive bladder cancer. Eur J Surg Oncol. 2010;36:292–7.

5. Winquist E, Kirchner TS, Segal R, Chin J, Lukka H. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis. J Urol. 2004;171:561–9.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of histological subtype and chemotherapy on prognosis of ureteral cancer;Journal of Cancer Research and Clinical Oncology;2024-04-13

2. Management of Bladder Cancer Patients with Clinical Evidence of Lymph Node Invasion (cN+);Cancers;2022-10-27

3. Multicenter evaluation of neoadjuvant and induction gemcitabine–carboplatin versus gemcitabine–cisplatin followed by radical cystectomy for muscle-invasive bladder cancer;World Journal of Urology;2022-09-28

4. Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis;UROL J;2022

5. Neoadjuvant Therapy for Cisplatin Ineligible Muscle Invasive Bladder Cancer Patients: A Review of Available Evidence;Urology;2021-08